Inventor · disambiguated record
Moriya Tsuji
Also filed as: TSUJI MORIYA
13 granted patents·7 pending applications·185 citations·filing 2002–2023
92Inventor score
Top patents by PatentIndex Score
20 records- 0196US7923013B2Glycolipids and analogues thereof as antigens for NKT cellsUNIV ROCKEFELLER·Filed 2007·Granted Apr 12, 2011·34 cites·20 claims
- 0291US7273852B2Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseasesUNIV CITY·Filed 2003·Granted Sep 25, 2007·54 cites·9 claims
- 0390US7488491B2Use of glycosylceramides as adjuvants for vaccines against infections and cancerUNIV NEW YORK·Filed 2002·Granted Feb 10, 2009·46 cites·17 claims
- 0488US8163290B2Glycolipids and analogues thereof as antigens for NKT cellsTSUJI MORIYA·Filed 2010·Granted Apr 24, 2012·14 cites·19 claims
- 0585US9278125B2Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvantsSANARIA INC·Filed 2013·Granted Mar 8, 2016·7 cites·6 claims
- 0683US9642909B2Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvantsSANARIA INC·Filed 2016·Granted May 9, 2017·4 cites·16 claims
- 0780US7534434B2Glycolipids and analogues thereof as antigens for NK T cellsUNIV ROCKEFELLER·Filed 2005·Granted May 19, 2009·5 cites·18 claims
- 0875US9555089B2Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopesSHIRATSUCHI TAKAYUKI·Filed 2012·Granted Jan 31, 2017·8 cites·16 claims
- 0969US8883745B2C—glycolipids with enhanced Th-1 profileTSUJI MORIYA·Filed 2007·Granted Nov 11, 2014·1 cites·22 claims
- 1066US7771726B2Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseasesUNIV NEW YORK·Filed 2004·Granted Aug 10, 2010·12 cites·38 claims
- 1160US2014186378A1Glycolipids and analogues thereof as antigens for nkt cellsSCRIPPS RESEARCH INST·Filed 2013·Application pending·0 cites
- 1258US2025367225A17dw8-5 treatment for covid-19 and other virus-induced respiratory infectionsUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 1356US2009233875A1Glycolipids and analogues thereof as antigens for nk t cellsUNIV ROCKEFELLER·Filed 2009·Application pending·0 cites
- 1455US8586051B2Glycolipids and analogues thereof as antigens for NKT cellsTSUJI MORIYA·Filed 2012·Granted Nov 19, 2013·0 cites·20 claims
- 1554US9155789B2Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune diseaseTSUJI MORIYA·Filed 2006·Granted Oct 13, 2015·0 cites·25 claims
- 1654US2009117089A1Glycolipids and analogues thereof as antigens for nk t cellsUNIV ROCKEFELLER·Filed 2006·Application pending·0 cites
- 1753US8252909B2Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseasesTSUJI MORIYA·Filed 2005·Granted Aug 28, 2012·0 cites·2 claims
- 1850US2012288525A1Pharmaceutical compositions comprising attenuated plasmodium sporozoites and glycolipid adjuvantsCHAKRAVARTY SUMANA·Filed 2012·Application pending·0 cites
- 1939US2005222048A1Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseasesUNIV NEW YORK·Filed 2005·Application pending·0 cites
- 2038US2017348405A1Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopesUNIV ROCKEFELLER·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Moriya Tsuji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →